Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 199174-24-8 | MDL No. : | MFCD03094726 |
Formula : | C10H19NO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HKIGXXRMJFUUKV-QMMMGPOBSA-N |
M.W : | 201.26 | Pubchem ID : | 1514341 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.9 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 57.75 |
TPSA : | 49.77 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.95 cm/s |
Log Po/w (iLOGP) : | 2.45 |
Log Po/w (XLOGP3) : | 0.82 |
Log Po/w (WLOGP) : | 0.85 |
Log Po/w (MLOGP) : | 0.86 |
Log Po/w (SILICOS-IT) : | 0.65 |
Consensus Log Po/w : | 1.13 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.34 |
Solubility : | 9.19 mg/ml ; 0.0457 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.45 |
Solubility : | 7.19 mg/ml ; 0.0357 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.83 |
Solubility : | 29.8 mg/ml ; 0.148 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.65 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
73% | Resolution of racemate | Racemic l-t-butoxycarbonylpyrrolidine-3-methanol (15 g,74.53 mmol) was chromatographed on a chiral column[ChiralPak AD 8 X 25 cm; 2.5percent of (6percent MeOH/94percent EtOH); 400mL/min; UV: 210 nm] to give l-t-butoxycarbonylpyrrolidine-3-methanol:Isomer I (Rt: 8.81 min, ChiralPak AD 4.6 X 250 mm; 1.0mL/min; UV: 210 nm) (6.35 g, 42percent, 94percent ee) andIsomer II (Rt: 9.68 min)' (6.43 g, 43percent, 90percent ee) .Isomer I: FIA-MS, m/e: 202.2 (rrH-1) .Isomer II: FIA-MS, m/e: 202.2 (m+1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
53% | Stage #1: With carbonochloridic acid 1-chloro-ethyl ester In 1,2-dichloro-ethane for 5 h; Reflux Stage #2: With N-ethyl-N,N-diisopropylamine In 1,2-dichloro-ethane for 3 h; Reflux Stage #3: With potassium carbonate In tetrahydrofuran; water at 0℃; for 3 h; |
(4) To a solution of (3^-3-([fer^butyl(dimethyl)silyl]oxy}methyl)"l-[(liS-l'phenylethyl]pyrrolidine (8.81 g, 27.6 mmol) in 1,2-dichloroethane (75 ml) was added 1-chloroethyl chloroformate (8.1 ml, 75 mmol) at room temperature. The resulting mixture was refluxed for 5 hours and cooled to room temperature. To the brown solution was added diisopropylethylamine (2.3 ml, 13 mmol). The mixture was refluxed for additional 3 hours and concentrated. The residue was diluted with ethyl acetate and washed with IN aqueous hydrochloric acid. The organic layer was dried over anhydrous sodium sulfate and concentrated in vacuo. The residue was dissolved in methanol (75 ml) and refluxed for one hour. After concentration under reduced pressure, IN aqueous hydrochloric acid was added. The aqueous solution was washed with ethyl acetate and basified by solid potassium carbonate. The basic solution was cooled to 0 T) and a solution of v terfrbutyl dicarbonate (6.3 g, 29 mmol) in tetrahydrofuran (75 ml) was added. The resulting mixture was stirred for 3 hours. The organic materials were extracted with ethyl acetate and dried over anhydrous sodium sulfate. The solvent was removed under reduced pressure and the residue was purified by silica gel column chromatography (eluent;hexane/ethyl acetate = 3/1 to 1/2) to afford C-oe-ferf-butyl 3-(hydroxymethyl)pyrrolidine- 1-carboxylate (2.96 g, 14.7 mmol, 53percent) as a colorless oil. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
73% | Resolution of racemate | Racemic l-t-butoxycarbonylpyrrolidine-3-methanol (15 g,74.53 mmol) was chromatographed on a chiral column[ChiralPak AD 8 X 25 cm; 2.5percent of (6percent MeOH/94percent EtOH); 400mL/min; UV: 210 nm] to give l-t-butoxycarbonylpyrrolidine-3-methanol:Isomer I (Rt: 8.81 min, ChiralPak AD 4.6 X 250 mm; 1.0mL/min; UV: 210 nm) (6.35 g, 42percent, 94percent ee) andIsomer II (Rt: 9.68 min)' (6.43 g, 43percent, 90percent ee) .Isomer I: FIA-MS, m/e: 202.2 (rrH-1) .Isomer II: FIA-MS, m/e: 202.2 (m+1). |
[ 663172-78-9 ]
N-Boc-6-hydroxy-3-azabicyclo[3.2.0]heptane
Similarity: 0.94
[ 140695-85-8 ]
(R)-tert-Butyl 3-(hydroxymethyl)piperidine-1-carboxylate
Similarity: 0.94
[ 116574-71-1 ]
tert-Butyl 3-(hydroxymethyl)piperidine-1-carboxylate
Similarity: 0.94
[ 140695-84-7 ]
tert-Butyl (S)-3-(hydroxymethyl)piperidine-1-carboxylate
Similarity: 0.94
[ 419572-18-2 ]
rel-(1R,5S,6r)-tert-Butyl 6-(hydroxymethyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate
Similarity: 0.92
[ 663172-78-9 ]
N-Boc-6-hydroxy-3-azabicyclo[3.2.0]heptane
Similarity: 0.94
[ 140695-85-8 ]
(R)-tert-Butyl 3-(hydroxymethyl)piperidine-1-carboxylate
Similarity: 0.94
[ 116574-71-1 ]
tert-Butyl 3-(hydroxymethyl)piperidine-1-carboxylate
Similarity: 0.94
[ 140695-84-7 ]
tert-Butyl (S)-3-(hydroxymethyl)piperidine-1-carboxylate
Similarity: 0.94
[ 419572-18-2 ]
rel-(1R,5S,6r)-tert-Butyl 6-(hydroxymethyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate
Similarity: 0.92
[ 663172-78-9 ]
N-Boc-6-hydroxy-3-azabicyclo[3.2.0]heptane
Similarity: 0.94
[ 140695-85-8 ]
(R)-tert-Butyl 3-(hydroxymethyl)piperidine-1-carboxylate
Similarity: 0.94
[ 116574-71-1 ]
tert-Butyl 3-(hydroxymethyl)piperidine-1-carboxylate
Similarity: 0.94
[ 140695-84-7 ]
tert-Butyl (S)-3-(hydroxymethyl)piperidine-1-carboxylate
Similarity: 0.94
[ 419572-18-2 ]
rel-(1R,5S,6r)-tert-Butyl 6-(hydroxymethyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate
Similarity: 0.92
[ 199174-29-3 ]
(R)-tert-Butyl 3-(aminomethyl)pyrrolidine-1-carboxylate
Similarity: 0.92
[ 199175-10-5 ]
(S)-1-Boc-3-(Aminomethyl)pyrrolidine
Similarity: 0.92
[ 274692-08-9 ]
(S)-tert-Butyl 3-(2-aminoethyl)pyrrolidine-1-carboxylate
Similarity: 0.92
[ 270912-72-6 ]
tert-Butyl 3-(aminomethyl)pyrrolidine-1-carboxylate
Similarity: 0.92
[ 849935-87-1 ]
(3S,4S)-tert-Butyl 3-hydroxy-4-(hydroxymethyl)pyrrolidine-1-carboxylate
Similarity: 0.91